Skip to content
  • Sunday, 26 July 2026
  • 4:30 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Critical Reviews in Biochemistry and Molecular Biology Seeks Visionary Editor-in-Chief to Guide Future of Research Synthesis
Biotech & Genetic Research

Critical Reviews in Biochemistry and Molecular Biology Seeks Visionary Editor-in-Chief to Guide Future of Research Synthesis

Jia Lissa Mar 23, 2026 0

The esteemed journal, Critical Reviews in Biochemistry and Molecular Biology, a flagship publication within the Taylor & Francis portfolio, has…

Read More
Advanced Materials Science

University of Cambridge Researchers Revolutionize Pharmaceutical Synthesis with Sustainable Light-Driven Chemical Reaction

Nila Kartika Wati Mar 14, 2026 0

In a landmark study published on March 12 in the journal Nature Synthesis, a team of researchers at the University…

Read More

Posts pagination

1 2
Gilead Sciences Finalizes $5 Billion Acquisition of Tubulis, Bolstering Oncology Pipeline with Advanced ADC TechnologyProtein SORLA Identified as Critical Defense Mechanism Against Toxic Tau Tangles in Alzheimer’s Disease and Related TauopathiesBioNTech’s Dramatic Pivot: From €19B COVID Vaccine Fortunes to 1,860 Job Cuts and a €16.8B Oncology BetPython Project Setup 2026: uv + Ruff + Ty + Polars
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ